What CAREFUSION Corp's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Friel Robert F | Director | Mar 17 | Disposition to Issuer · D | +34,103 | — | — | 0 |
| Hinrichs James F. | Chief Financial Officer | Mar 17 | Disposition to Issuer · D | −187,105 | — | — | 0 |
| Lucier Gregory T | Director | Mar 17 | Disposition to Issuer · D | −34,103 | — | — | 0 |
| Gallahue Kieran | Chairman and CEO | Mar 17 | Disposition to Issuer · D | −740,251 | — | — | 0 |
| Losh J Michael | Director | Mar 17 | Disposition to Issuer · D | −750 | — | — | 0 |
| Losh J Michael | Director | Mar 17 | Disposition to Issuer · D | −31,756 | — | — | 0 |
| Kosecoff Jacqueline B | Director | Mar 17 | Disposition to Issuer · D | −34,103 | — | — | 0 |
| Abbey Donald | EVP, Quality Reg & Med Affairs | Mar 17 | Disposition to Issuer · D | −73,178 | — | — | 0 |
| Wygant Jonathan | SVP, Chief Accounting Officer | Mar 17 | Disposition to Issuer · D | −5,068 | — | — | 0 |
| La Fortune Gordon | EVP, EMEA/ANZ Commercial Ops | Mar 17 | Disposition to Issuer · D | −25,415 | — | — | 0 |
| Leonard Thomas J | President, Medical Systems | Mar 17 | Disposition to Issuer · D | +92,214 | — | — | 0 |
| Stafslien Joan | EVP, General Counsel | Mar 17 | Disposition to Issuer · D | −93,563 | — | — | 0 |
| Bose Supratim | Director | Mar 17 | Disposition to Issuer · D | −2,059 | — | — | 0 |
| Miller Edward D Jr | Director | Mar 17 | Disposition to Issuer · D | −34,103 | — | — | 0 |
| Ohalleran Michael D | Director | Mar 17 | Disposition to Issuer · D | −3,750 | — | — | 0 |
| Ohalleran Michael D | Director | Mar 17 | Disposition to Issuer · D | −45,759 | — | — | 0 |
| Gallahue Kieran | Chairman and CEO | Mar 11 | Withheld — tax / exercise cost · F | −1,103,089 | $59.73 | −$65.9M | 740,251 |
| Gallahue Kieran | Chairman and CEO | Mar 11 | Exercise / conversion · M | +133,215 | $36.17 | +$4.82M | 1,843,340 |
| Gallahue Kieran | Chairman and CEO | Mar 11 | Exercise / conversion · M | +318,928 | $26.79 | +$8.54M | 1,710,125 |
| Gallahue Kieran | Chairman and CEO | Mar 11 | Exercise / conversion · M | +503,306 | $25.56 | +$12.9M | 1,391,197 |
Loading...
